» Articles » PMID: 30266410

HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas

Overview
Specialty Biology
Date 2018 Sep 30
PMID 30266410
Citations 164
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is highly heterogeneous in nature and has been one of the most common cancer types worldwide. To ensure repeatability of identified gene expression patterns and comprehensively annotate the transcriptomes of HCC, we carefully curated 15 public HCC expression datasets that cover around 4000 clinical samples and developed the database HCCDB to serve as a one-stop online resource for exploring HCC gene expression with user-friendly interfaces. The global differential gene expression landscape of HCC was established by analyzing the consistently differentially expressed genes across multiple datasets. Moreover, a 4D metric was proposed to fully characterize the expression pattern of each gene by integrating data from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx). To facilitate a comprehensive understanding of gene expression patterns in HCC, HCCDB also provides links to third-party databases on drug, proteomics, and literatures, and graphically displays the results from computational analyses, including differential expression analysis, tissue-specific and tumor-specific expression analysis, survival analysis, and co-expression analysis. HCCDB is freely accessible at http://lifeome.net/database/hccdb.

Citing Articles

NOL-7 serves as a potential prognostic-related biomarker for hepatocellular carcinoma.

Lei Q, Huang Y, Deng F, Zheng H, Hong X, Wang P Discov Oncol. 2025; 16(1):69.

PMID: 39836310 PMC: 11751243. DOI: 10.1007/s12672-024-01551-7.


Discovering novel prognostic biomarkers of hepatocellular carcinoma using eXplainable Artificial Intelligence.

Gutierrez-Chakraborty E, Chakraborty D, Das D, Bai Y Expert Syst Appl. 2025; 252(Pt B.

PMID: 39829683 PMC: 11737334. DOI: 10.1016/j.eswa.2024.124239.


Development of a Novel four-gene Model for Monitoring the Progression from Metabolic Dysfunction-associated Steatotic Liver Disease to Hepatocellular Carcinoma in Males.

Jiang Y, Chen J, Xu L, Lv L, Gan X J Cancer. 2025; 16(3):917-931.

PMID: 39781352 PMC: 11705051. DOI: 10.7150/jca.100724.


PAXIP1 is regulated by NRF1 and is a prognosis‑related biomarker in hepatocellular carcinoma.

Cheng Q, Han X, Xie H, Liao Y, Wang F, Cui X Biomed Rep. 2025; 22(3):38.

PMID: 39781045 PMC: 11704871. DOI: 10.3892/br.2024.1916.


Integrative multi-omics analysis reveals a novel subtype of hepatocellular carcinoma with biological and clinical relevance.

Li S, Lin Y, Gao X, Zeng D, Cen W, Su Y Front Immunol. 2024; 15:1517312.

PMID: 39712016 PMC: 11659151. DOI: 10.3389/fimmu.2024.1517312.


References
1.
Guan X, Fang Y, Sham J, Kwong D, Zhang Y, Liang Q . Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer. 2000; 29(2):110-6. View

2.
Su W, Chao C, Yeh S, Chen D, Chen P, Jou Y . OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci. Nucleic Acids Res. 2006; 35(Database issue):D727-31. PMC: 1669730. DOI: 10.1093/nar/gkl845. View

3.
Yamashita T, Forgues M, Wang W, Kim J, Ye Q, Jia H . EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res. 2008; 68(5):1451-61. DOI: 10.1158/0008-5472.CAN-07-6013. View

4.
Bleeker F, Lamba S, Rodolfo M, Scarpa A, Leenstra S, Vandertop W . Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes. Hum Mutat. 2008; 30(2):E451-9. DOI: 10.1002/humu.20927. View

5.
Hoshida Y, Nijman S, Kobayashi M, Chan J, Brunet J, Chiang D . Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 2009; 69(18):7385-92. PMC: 3549578. DOI: 10.1158/0008-5472.CAN-09-1089. View